Background Image
Table of Contents Table of Contents
Previous Page  9 / 68 Next Page
Information
Show Menu
Previous Page 9 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 6, November/December 2015

AFRICA

207

On the other hand, a statistically significant difference was not

detected between H-FABP, TnI and CK-MB levels in the patient

group that was admitted after more than six hours (

n

=

14). Figs

1 and 2 compare the AI values of the cardiac markers according

to admission times after onset of symptoms.

False-negative results were obtained in four patients who

were tested for H-FABP, and false-positive results were obtained

in two. Although all characteristics of these six patients were

reviewed in detail with the hope of finding any predictors for

false negativity and false positivity, no characteristics could be

detected to explain this condition.

Discussion

In our study, the role of bedside H-FABP measurement was

investigated in 48 patients who were admitted to the emergency

room within 12 hours of onset of chest pain lasting for more

than 30 minutes and who did not have ST-segment elevation on

ECG. It was concluded that H-FABP was a better diagnostic

marker than CK-MB and Tn I, with high sensitivity (79%) and

specificity (93%) (AI

=

85%) for early diagnosis of NSTEMI (

six hours). In addition, the sensitivity and specificity of H-FABP

for the group admitted

three hours of onset of symptoms were

calculated as 89 and 100%, respectively.

H-FABP is seen as a novel cardiac marker in the diagnosis

of ACS. Nakata

et al

.

22

and O’Donoghue

et al.

23

have shown it

to be an early diagnostic and prognostic marker. It begins to

elevate in the plasma within one to three hours following the

initial symptoms of ACS and decreases to normal levels within

24 to 36 hours.

10

A few immunohistochemical methods are used for the

detection of H-FABP levels and these take from 45 minutes to

16 hours. This time decreases to 15 minutes with CardioDetect,

a single-step, qualitative bedside test. Values

>

7 mg/l are seen

as positive.

20

In a previous study conducted on 38 patients, this

bedside method was compared with the ELISA method, which is

used for the quantitative measurement of H-FABP levels, and it

was completed in 45 minutes. These two methods were therefore

similarly successful in making a diagnosis.

20,24

Recent studies in the literature on the diagnostic value of

H-FABP in ACS have given controversial results.

25,26

Some

studies showed H-FABP to be a reliable diagnostic tool for the

early diagnosis of ACS/MI,

14-16

and others displayed negative

results.

17-19

In the study by Glatz

et al

.

9

conducted on 83 patients, the

diagnostic sensitivity of H-FABP was shown to be better than

that of myoglobin in patients who were admitted within six

hours of onset of symptoms (78 vs 53%,

p

<

0.05). Similarly,

in the study by Haastrup

et al

.,

27

which was conducted on

130 patients who did not have ST-segment elevation and were

admitted in under six hours, the sensitivity of H-FABP was

found to be 90–95% and specificity was 81–94% for different

reference values. Myoglobin and H-FABP were reported to be

useful markers in the early triage of patients with chest pain.

In the study by Yoshihiko

et al

., which was conducted on

129 patients suspected of AMI, the sensitivity of H-FABP was

found to be 100% and specificity was 63% in the first three

hours.

28

Patients with STEMI were included this study. In the

same study, the sensitivity of troponin T (TnT) was found to

be 50% and specificity was 96% in the first three hours. They

concluded that H-FABP was a more valid marker than TnT in

Table 5. Diagnostic value of H-FABP, TnI and CK-MB in

NSTEMI diagnosis, according to admission time after

onset of symptoms (

6 and

>

6 hours)

6 hours (

n

=

34)

>

6 hours (

n

=

14)

H-FABP

Sensitivity (%)

79

100

Specificity (%)

93

89

NPV (%)

78

100

PPV (%)

94

83

AI (%)

85

93

TnI

Sensitivity (%)

53

100

Specificity (%)

80

89

NPV (%)

57

100

PPV (%)

77

83

AI (%)

65

93

CK-MB mass

Sensitivity (%)

37

100

Specificity (%)

93

100

NPV (%)

54

100

PPV (%)

88

100

AI (%)

62

100

Accuracy index (%)

3 h

3–6 h

>

6 h

100

90

80

70

60

50

40

30

20

10

0

Tnl

H-FABP

CK-MB

p

<

0.01

p

<

0.05

p

>

0.05

Fig. 1.

AI values of H-FABP, TnI, and CK-MB for the diagnosis

of NSTEMI according to admission times (

3, 3–6,

and

>

6 hours).

Accuracy index (%)

6 h

>

6 h

100

90

80

70

60

50

40

30

20

10

0

Tnl

H-FABP

CK-MB

p

<

0.05

p

>

0.05

Fig. 2.

AI values of H-FABP, TnI and CK-MB for the diagnosis

of NSTEMI according to admission times (

6 and

>

6 hours).